Cellebrite DI Ltd at UBS Global Technology and AI Conference Transcript
Guys, thank you for joining today. My name is Steve Pettigrew. I lead the Software Investment Banking business at UBS. Pleased to have with me today David Barter, Chief Financial Officer; and Tom Hogan, Chief Executive Officer of Cellebrite. For those of you who don't know Cellebrite, digital investigations market leader, and we'll talk through a little bit more about what that means today.
Tom, maybe you can start us off. Can you share for kind of people who aren't as familiar, a little bit of background about Cellebrite and your history?
Yeah. So the company, roughly 20 years old, obviously, public, NASDAQ listed. The genesis of the company is in Israel, where the core of our research and development still sits today, but we have a huge presence around the world; operate very internationally, do 55% or so of our business in the United States and 45% in the rest of the world. And what we do, we're a force for good for all of you. Whoever is here,
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

